BR0311613A - Métodos para inibição, tratamento ou prevenção de sintomas de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres e utilização de composto - Google Patents
Métodos para inibição, tratamento ou prevenção de sintomas de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres e utilização de compostoInfo
- Publication number
- BR0311613A BR0311613A BR0311613-1A BR0311613A BR0311613A BR 0311613 A BR0311613 A BR 0311613A BR 0311613 A BR0311613 A BR 0311613A BR 0311613 A BR0311613 A BR 0311613A
- Authority
- BR
- Brazil
- Prior art keywords
- atrophy
- women
- epithelial
- treating
- compound
- Prior art date
Links
- 206010040799 Skin atrophy Diseases 0.000 title abstract 3
- 206010067994 Mucosal atrophy Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 title abstract 2
- 206010003694 Atrophy Diseases 0.000 abstract 1
- 206010028289 Muscle atrophy Diseases 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 230000020763 muscle atrophy Effects 0.000 abstract 1
- 201000000585 muscular atrophy Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
Abstract
"MéTODOS PARA INIBIçãO, TRATAMENTO OU PREVENçãO DE SINTOMAS DE ATROFIA DA PELE, OU ATROFIA EPITELIAL OU DA MUCOSA NAS MULHERES E UTILIZAçãO DE COMPOSTO". Refere-se a presente invenção a um método para inibição de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres, ou a um método para tratamento ou prevenção de sintomas relacionados com atrofia, o dito método compreendendo administrar à mulher uma quantidade efetiva do composto da fórmula (I) ou um isómero geométrico, um estereoisómero, um sal farmaceuticamente aceitável, um éster do mesmo ou um metabolito do mesmo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38590402P | 2002-06-06 | 2002-06-06 | |
PCT/FI2003/000369 WO2003103649A1 (en) | 2002-06-06 | 2003-05-14 | Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0311613A true BR0311613A (pt) | 2005-03-08 |
Family
ID=29736123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0311613-1A BR0311613A (pt) | 2002-06-06 | 2003-05-14 | Métodos para inibição, tratamento ou prevenção de sintomas de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres e utilização de composto |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1509215B1 (pt) |
JP (1) | JP4362442B2 (pt) |
KR (1) | KR100991157B1 (pt) |
CN (2) | CN101406464A (pt) |
AT (1) | ATE344025T1 (pt) |
AU (1) | AU2003227790B2 (pt) |
BR (1) | BR0311613A (pt) |
CA (1) | CA2484542C (pt) |
CY (1) | CY1105787T1 (pt) |
DE (1) | DE60309465T2 (pt) |
DK (1) | DK1509215T3 (pt) |
ES (1) | ES2270025T3 (pt) |
HR (1) | HRP20041150B1 (pt) |
IL (1) | IL164528A (pt) |
MX (1) | MXPA04012220A (pt) |
NO (3) | NO334090B1 (pt) |
NZ (1) | NZ536118A (pt) |
PL (1) | PL214242B1 (pt) |
PT (1) | PT1509215E (pt) |
RU (1) | RU2317816C2 (pt) |
SI (1) | SI1509215T1 (pt) |
UA (1) | UA79797C2 (pt) |
WO (1) | WO2003103649A1 (pt) |
ZA (1) | ZA200408321B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8236861B2 (en) | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
US8642079B2 (en) | 2004-02-23 | 2014-02-04 | Hormos Medical Corporation | Solid formulations of ospemifene |
AU2005237274B2 (en) | 2004-05-04 | 2011-02-17 | Hormos Medical Ltd | Novel oral formulations of ospemifene |
US8758821B2 (en) | 2004-05-04 | 2014-06-24 | Hormos Medical Ltd. | Oral formulations of ospemifene |
AU2007256718A1 (en) | 2006-06-02 | 2007-12-13 | Pear Tree Women's Health Care | Method of treating atrophic vaginitis |
US7504530B2 (en) | 2007-02-14 | 2009-03-17 | Hormos Medical Ltd. | Methods for the preparation of fispemifene from ospemifene |
SI2121553T1 (sl) | 2007-02-14 | 2012-11-30 | Hormos Medical Ltd | Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov |
US9321712B2 (en) | 2012-10-19 | 2016-04-26 | Fermion Oy | Process for the preparation of ospemifene |
KR102052133B1 (ko) | 2017-08-10 | 2019-12-05 | 고려대학교 산학협력단 | 당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352699A (en) * | 1992-04-30 | 1994-10-04 | University Of Massachusetts Medical Center | Use of retinioc acid to treat vaginal atrophy |
US5461064A (en) * | 1993-12-21 | 1995-10-24 | Eli Lilly And Company | Methods of inhibiting atrophy of the skin and vagina |
US5747059A (en) * | 1996-01-11 | 1998-05-05 | Novo Nordisk A/S | Atrophy of skin/mucous membrane |
PL357163A1 (en) * | 2000-01-28 | 2004-07-26 | Endorecherche, Inc. | Selective estrogen receptor modulators in combination with estrogens |
US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
US6245819B1 (en) * | 2000-07-21 | 2001-06-12 | Hormos Medical Oy, Ltd. | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
-
2003
- 2003-05-14 WO PCT/FI2003/000369 patent/WO2003103649A1/en active IP Right Grant
- 2003-05-14 CN CNA2008101733358A patent/CN101406464A/zh active Pending
- 2003-05-14 CA CA2484542A patent/CA2484542C/en not_active Expired - Lifetime
- 2003-05-14 AU AU2003227790A patent/AU2003227790B2/en not_active Expired
- 2003-05-14 PL PL372758A patent/PL214242B1/pl unknown
- 2003-05-14 EP EP03725238A patent/EP1509215B1/en not_active Expired - Lifetime
- 2003-05-14 BR BR0311613-1A patent/BR0311613A/pt not_active Application Discontinuation
- 2003-05-14 KR KR1020047019843A patent/KR100991157B1/ko active IP Right Grant
- 2003-05-14 JP JP2004510768A patent/JP4362442B2/ja not_active Expired - Lifetime
- 2003-05-14 MX MXPA04012220A patent/MXPA04012220A/es active IP Right Grant
- 2003-05-14 ES ES03725238T patent/ES2270025T3/es not_active Expired - Lifetime
- 2003-05-14 DK DK03725238T patent/DK1509215T3/da active
- 2003-05-14 UA UAA200500144A patent/UA79797C2/uk unknown
- 2003-05-14 CN CNB038128780A patent/CN100448437C/zh not_active Expired - Lifetime
- 2003-05-14 AT AT03725238T patent/ATE344025T1/de active
- 2003-05-14 DE DE60309465T patent/DE60309465T2/de not_active Expired - Lifetime
- 2003-05-14 PT PT03725238T patent/PT1509215E/pt unknown
- 2003-05-14 SI SI200330601T patent/SI1509215T1/sl unknown
- 2003-05-14 NZ NZ536118A patent/NZ536118A/en not_active IP Right Cessation
- 2003-05-14 RU RU2004138571/14A patent/RU2317816C2/ru active
-
2004
- 2004-10-12 IL IL164528A patent/IL164528A/en active IP Right Grant
- 2004-10-14 ZA ZA200408321A patent/ZA200408321B/en unknown
- 2004-10-22 NO NO20044568A patent/NO334090B1/no not_active IP Right Cessation
- 2004-12-02 HR HR20041150A patent/HRP20041150B1/xx not_active IP Right Cessation
-
2006
- 2006-11-15 CY CY20061101664T patent/CY1105787T1/el unknown
-
2013
- 2013-09-04 NO NO20131189A patent/NO336612B1/no not_active IP Right Cessation
-
2015
- 2015-04-22 NO NO20150487A patent/NO339194B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
BR0214962A (pt) | Composição para tratar distúrbios neurocerebrovasculares | |
PT1305014E (pt) | Metodo para o tratamento de disturbios climatericos em mulheres durante ou apos a menopausa | |
BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
CA2632207C (en) | Use of calcitonin for the treatment of ra | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
EP1348466A3 (en) | Method for treating pain with adenosine-tetraphosphates | |
CY1105787T1 (el) | Θepαπευτικη αντιμετωπιση η προληψη της ατροφιας του ουροποιογεννητικου συστηματος και τα συμπτωματα της σε γυναικες | |
BRPI0418973A (pt) | composições de risedronato e seus métodos de uso | |
BRPI0413404A (pt) | composições farmacêuticas, métodos de tratamento ou prevenção de disfunções cardìacas, métodos de aumento da função cardìaca e método de identificação de inibidor de mif | |
BR0314081A (pt) | Terapia de combinação compreendendo um bisfosfonato e um inibidor de hmg-coa redutase | |
BR0310061A (pt) | Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições | |
CO5261512A1 (es) | Metodo y composiciones para el tratamiento de las enfermedades pulmonares | |
AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
BR0115215A (pt) | Método para o tratamento de inflamações | |
UY30557A1 (es) | Tratamiento y prevencion de la fibrosis intestinal | |
CL2021003312A1 (es) | Composición que comprende pridopidina y un análogo de la misma para el tratamiento de la enfermedad de huntington y síntomas de la misma. | |
CL2021003303A1 (es) | Tratamiento para sinucleinopatías. | |
WO2001068076A8 (en) | D-enantiomer of dfmo and methods of use thereof for treating cancer | |
PL371264A1 (en) | Method for the treatment of bone disorders | |
BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
WO2004112565A3 (en) | Diagnosis and treatment of liver, pulmonary and cardiac fibrosis | |
ATE248607T1 (de) | Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen | |
CA2403674A1 (en) | The use of t3 for treating congestive heart failure | |
BR0313204A (pt) | Métodos para tratamento e prevenção de condições gastrointestinais |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA:INT.CI. A61K 31/085, A61P 15/00, A61P 15/12 Ipc: A61K 31/085 (2011.01), A61P 15/00 (2011.01), A61P |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |